117 related articles for article (PubMed ID: 12632075)
1. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
Lin S; Li JJ; Fujii M; Hou DX
Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
Zhong S; Quealy JA; Bode AM; Nomura M; Kaji A; Ma WY; Dong Z
Cancer Res; 2001 May; 61(10):4084-91. PubMed ID: 11358830
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; IƱiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Won YK; Ong CN; Shi X; Shen HM
Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901
[TBL] [Abstract][Full Text] [Related]
6. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
7. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
8. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB.
Huang Q; Shen HM; Ong CN
Biochem Pharmacol; 2004 Jul; 68(2):361-71. PubMed ID: 15194008
[TBL] [Abstract][Full Text] [Related]
10. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
Liu G; Bode A; Ma WY; Sang S; Ho CT; Dong Z
Cancer Res; 2001 Aug; 61(15):5749-56. PubMed ID: 11479211
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid inhibits cardiac neural crest migration by blocking c-Jun N-terminal kinase activation.
Li J; Molkentin JD; Colbert MC
Dev Biol; 2001 Apr; 232(2):351-61. PubMed ID: 11401397
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
14. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
Balaraman S; Singh VK; Tewary P; Madhubala R
Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells.
Hirata Y; Furuta K; Miyazaki S; Suzuki M; Kiuchi K
Brain Res; 2004 Sep; 1021(2):241-7. PubMed ID: 15342272
[TBL] [Abstract][Full Text] [Related]
17. Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38.
Ohsawa M; Koyama T; Nara N; Hirosawa S
Thromb Res; 2003; 112(5-6):313-20. PubMed ID: 15041276
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
Dong Z; Ma W; Huang C; Yang CS
Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
[TBL] [Abstract][Full Text] [Related]
20. Asbestos induces activator protein-1 transactivation in transgenic mice.
Ding M; Dong Z; Chen F; Pack D; Ma WY; Ye J; Shi X; Castranova V; Vallyathan V
Cancer Res; 1999 Apr; 59(8):1884-9. PubMed ID: 10213496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]